Prognostic factors in R/R AML are not yet well established; for example, the effects on OS of the duration of the first CR/CRi, cytogenetic status, the presence of FLT3-internal tandem duplication (ITD) mutations or previous allo-SCT are largely unknown. Here, FLT3 is linked to acute myeloid leukemia.